Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: A new personalized medical approach

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 8, 2014, Pages 1341-1343

  Glassock, Richard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPASE A2 RECEPTOR AUTOANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PHOSPHOLIPASE A2 RECEPTOR;

EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FUNCTION; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PATHOGENESIS; PERSONALIZED MEDICINE; PROTEINURIA; REMISSION; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; BLOOD; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; IMMUNOLOGY; MALE;

AUTOANTIBODIES; CYCLOPHOSPHAMIDE; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; RECEPTORS, PHOSPHOLIPASE A2;

EID: 84923804597     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05880614     Document Type: Editorial

References (20)

1. Bech AP, Hofstra JM, Brenchley PE, Wetzels JFM: Association of anti-PLA2R-antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 9: 1386–1392, 2014
2. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11–21, 2009
3. Euroimmun US: FDA allows marketing of first non-invasive test to help in identifying cause of certain kidney disease. May 29, 2014. Available at http://www.euroimmun.us/fda-released/newfda-release-pla2r-ifa.
4. US Food and Drug Administration http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K132195. Both Accessed June 27, 2014
5. Hofstra JM, Wetzels JFM: Phospholipase A2 receptor antibodies in membranous nephropathy: Unresolved issues. J Am Soc Nephrol 25: 1137–1139, 2014
6. Dähnrich C, Komorowski L, Probst C, Seitz-Polski B, Esnault V, Wetzels JF, Hofstra JM, Hoxha E, Stahl RA, Lambeau G, Stöcker W, Schlumberger W: Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta 421: 213–218, 2013
7. Hofstra JM, Debiec H, Short CD, Pellé T, Kleta R, Mathieson PW, Ronco P, Brenchley PE,Wetzels JF: Antiphospholipase A2 receptor antibody titer and subclass in idiopathicmembranous nephropathy. J Am Soc Nephrol 23: 1735–1743, 2012
8. Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RA: Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 25: 1357–1366, 2014
9. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ: Antiphospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6: 1286–1291, 2011
10. Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ: Rituximabinduced depletion of anti-PLA2R autoantibodies redicts response in membranous nephropathy. J Am Soc Nephrol 22: 1543–1550, 2011
11. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z: Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22: 1137–1143, 2011
12. Gunnarsson I, Schlumberger W, Rönnelid J: Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis. Am J Kidney Dis 59: 585–586, 2012
13. Knehtl M, Debiec H, Kamgang P, Callard P, Cadranel J, Ronco P, Boffa JJ: A case of phospholipase A2 receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis. Am J Kidney Dis 57: 140–143, 2011
14. Kanigicherla D, Gummadova J, McKenzie EA, Roberts SA, Harris S, Nikam M, Poulton K, McWilliam L, Short CD, Venning M, Brenchley PE: Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int 83: 940–948, 2013
15. Qu Z, Liu G, Li J, Wu LH, Tan Y, Zheng X, Ao J, Zhao MH: Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant 27: 1931–1937, 2012
16. Fervenza FC, Glassock RJ, Bleyer AJ: American Society of Nephrology Quiz and Questionnaire 2012: glomerulonephritis. Clin J Am Soc Nephrol 8: 1460–1465, 2013
17. Murtas C, Bruschi M, Candiano G, Moroni G, Magistroni R, Magnano A, Bruno F, Radice A, Furci L, Argentiero L, Carnevali ML, Messa P, Scolari F, Sinico RA, esualdo L, Fervenza FC, Allegri L, Ravani P, Ghiggeri GM: Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol 7: 1394–1400, 2012
18. KDIGO clinical practice guidelines for glomerulonephritis Kidney Int Suppl 2: 186–197, 2012
19. Svobodova B, Honsova E, Ronco P, Tesar V, Debiec H: Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2Rrelated membranous nephropathy. Nephrol Dial Transplant 28: 1839–1844, 2013
20. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, Voinescu C, Patel N, Pearce K, Hubank M, Stephens HA, Laundy V, Padmanabhan S, Zawadzka A, Hofstra JM, Coenen MJ, den Heijer M, Kiemeney LA, Bacq-Daian D, Stengel B, Powis SH, Brenchley P, Feehally J, Rees AJ, Debiec H, Wetzels JF, Ronco P, Mathieson PW, Kleta R: Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 364: 616–626, 2011